MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody for the treatment of inflammation diseases. MLTX $28.5400 1.2300 % 4.5000 Moonlake Immunotherapeutics Sector : Medical Industry : Medical – Biomedical Signal Short Term Trend Long Term Trend BUY UP UP Day: 4.5% Wk: 1.6% Mo: 35.58% […]